title: Factors determining a low dose of haemodialysis as measured by ionic dialysance in critical patients with acute kidney injury.
abstract: BACKGROUND
  Estimating the dialysis dose is a requirement commonly used to assess the quality of renal replacement therapy (RRT) in patients with chronic kidney disease (CKD). In patients with acute kidney injury (AKI), this value is not always evaluated and it has been estimated that the prescribed dose is seldom obtained. Reports addressing this issue in AKI individuals are scarce and most have not included an adequate number of patients or treatments, nor were patients treated with extended therapies. Kt values obtained by the ionic dialysance method have been validated for the evaluation of the dialysis dose and it has also been shown that, compared with Kt/V, this is the most sensitive strategy for revealing inadequate dialysis treatment in critically ill AKI individuals. The main aim of this study was to assess the difference between the prescribed and the administered dialysis dose in critically ill AKI patients, and to evaluate what factors determine this gap using Kt values assessed through ionic dialisance.
  
  
  METHODS
  Data from 394 sessions of renal replacement therapy in 105 adult haemodialysis (HD) patients with oliguric acute kidney injury and admitted to ICU were included in this analysis. RRT was carried out with Fresenius 4008E dialysis machines equipped with on-line clearance monitoring (OCM® Fresenius), which use non-invasive techniques to monitor the effective ionic dialysance, equivalent to urea clearance. The baseline characteristics of the study population as well as the prescription and outcome of RRT were analysed. These variables were included in a multivariate model in which the dependent variable was the failure to obtain the threshold dose (TD).
  
  
  RESULTS
  The main baseline characteristics of the study population/treatments were: age 66 ± 15 years, 37% female, most frequent cause of AKI: sepsis (70%). Low BP and/or vasoactive drug requirement (71%), mechanical ventilation (70%) and average individual severity index: 0.7 ± 0.26. Two hundred and one intermittent HD (IHD) and 193 extended HD (EHD) sessions were performed; the most frequently used temporary vascular access was the femoral vein catheter (79%). Prescribed Kt was 53.5 ± 14L and 21% of prescriptions fell below the TD. Sixty-one percent of treatments did not fulfill the TD (31 ± 8L) compared with 56 ± 12L obtained in the subgroup that achieved the target. Compared to IHD, EHD provided a significantly larger Kt (46 ± 16L vs 33L ± 9L). Univariate analysis showed that inadequate compliance was associated with age (>65y), male gender, intra-dialytic hypotension, low Qb, catheter line reversal, and IHD. The same variables with the exception of age and gender were independently associated in the multivariate analysis.
  
  
  CONCLUSIONS
  The dialysis dose obtained was significantly lower than that prescribed. EHD achieved values closer to the prescribed KT and significantly higher than in IHD. Ionic Kt measurement facilitates monitoring and allows HD treatments to be extended based upon a previously established TD. Besides the chosen strategy to dispense the dose of dialysis, a well-functioning vascular access allowing for optimal blood flow and other approaches aimed at avoiding hemodynamic instability during RRT are the most important factors to achieve TD, mainly in elderly male patients. The dialysis dose should be prescribed and monitored for all critically ill AKI patients.
authors.affiliation: Hospital Italiano de Buenos Aires, Argentina. guillermo.rosadiez@hospitalitaliano.org.ar
authors.forename: Guillermo
authors.initials: G
authors.lastname: Rosa-Diez
authors.forename: Gustavo
authors.initials: G
authors.lastname: Greloni
authors.forename: María
authors.initials: M
authors.lastname: Crucelegui
authors.forename: Mariela
authors.initials: M
authors.lastname: Bedini-Roca
authors.forename: Agustina
authors.initials: A
authors.lastname: Heredia-Martínez
authors.forename: M Luisa
authors.initials: ML
authors.lastname: Coli
authors.forename: Sergio
authors.initials: S
authors.lastname: Giannasi
authors.forename: Eduardo
authors.initials: E
authors.lastname: San-Román
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Pizarro
authors.forename: César
authors.initials: C
authors.lastname: Belzitti
authors.forename: Salomón
authors.initials: S
authors.lastname: Algranati
authors.forename: Ricardo
authors.initials: R
authors.lastname: Heguilen
mesh_terms: D058186:Acute Kidney Injury / Q000209:etiology / Q000628:therapy*; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000465:Algorithms; D004553:Electric Conductivity; D005260:Female; D015312:Hemodialysis Solutions / Q000008:administration & dosage* / Q000032:analysis; D006801:Humans; D007022:Hypotension / Q000453:epidemiology / Q000209:etiology; D007477:Ions / Q000032:analysis; D008297:Male; D019300:Medical Errors; D008875:Middle Aged; D009846:Oliguria / Q000209:etiology / Q000628:therapy; D011183:Postoperative Complications / Q000628:therapy; D055656:Prescriptions; D011446:Prospective Studies; D006435:Renal Dialysis / Q000009:adverse effects / Q000379:methods*; D012307:Risk Factors; D018805:Sepsis / Q000150:complications; D012720:Severity of Illness Index
chemical_list: D015312:Hemodialysis Solutions; D007477:Ions